Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplant

Bone Marrow Transplantation

Volumn 35, Issue 7, 2005, Pages 707-711

  Blijlevens, N M A ^a   Donnelly, J P ^a   de Pauw, B E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gut integrity; HSCT; Mucosal damage; Myeloablative therapy

Indexed keywords

3 METHYLGLUCOSE; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; IDARUBICIN; LACTULOSE; MELPHALAN; ONDANSETRON; RHAMNOSE; THYMOCYTE ANTIBODY; XYLOSE;

ABDOMINAL DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; FECES INCONTINENCE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL DISCHARGE; HUMAN; INTESTINE ABSORPTION; INTESTINE INJURY; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; MOUTH DISEASE; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; NAUSEA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; VOMITING; WHOLE BODY RADIATION;

ADULT; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDARUBICIN; INTESTINAL MUCOSA; LACTULOSE; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PERMEABILITY; PROSPECTIVE STUDIES; RHAMNOSE; STOMATITIS; TRANSPLANTATION CONDITIONING;

EID: 17144389024     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704863     Document Type: Article

References (17)

1. Parulekar W, Mackenzie R, Bjarnason G, Jordan RC. Scoring oral mucositis. Oral Oncol 1998; 34: 63-71.
2. Wardley AM, Jayson GC, Swindell R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haematopoietic progenitor rescue. Br J Haematol 2000; 110: 299.
3. Rapoport AP, Miller Watelet LF, Linder T et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 1999; 17: 2446-2453.
4. Blijlevens NMA, van't Land B, Donnelly JP et al. Measuring mucosal damage induced by cytotoxic therapy. Support Care Cancer 2004; 12: 227-233.
5. Schaap N, Schattenberg A, Bar B et al. Outcome of transplantation for standard-risk leukaemia with grafts depleted of lymphocytes after conditioning with an intensified regimen. Br J Haematol 1997; 98: 750-759.
6. Muus P, Donnelly P, Schattenberg A et al. Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent. Semin Oncol 1993; 20 (Suppl. 8): 47-52.
7. Donnelly JP, Muus P, Schattenberg A et al. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients. Bone Marrow Transplant 1992; 9: 409-413.
8. Jansen G, Muskiet FAJ, Schierbeek H et al. Capillary gas chromatographic profiling of urinary, plasma and erythrocyte sugars and polyols as their trimethylsilyl derivates, preceded by a simple and rapid prepurification method. Clin Chim Acta 1986; 157: 277-294.
9. Johnston JD, Harvey CJ, Menzies IS, Treacher DF. Gastrointestinal permeability and absorptive capacity in sepsis. Crit Care Med 1996; 24: 1144-1149.
10. Lim SG, Menzies IS, Lee CA et al. Intestinal permeability and function in patients infected with human immunodeficiency virus: a comparison with coeliac disease. Scand J Gastroenterol 1993; 28: 573-580.
11. Keefe DM, Cummins AG, Dale BM et al. Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci Colch 1997; 92: 385-389.
12. Ijiri K, Potten CS. Response of intestinal cells of differing topographical and hierarchical status to ten cytotoxic drugs and five sources of radiation. Br J Cancer 1983; 47: 175-185.
13. Keefe DMK, Brealey J, Goland GJ, Cummins AG. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47: 632-637.
14. Cummins AG, Thompson FM, Butler RN et al. Improvement in intestinal permeability precedes morphometric recovery of the small intestine in coeliac disease. Clin Sci 2001; 100: 379-386.
15. Verburg M, Renes IB, van Nispen DJPM et al. Specific responses in rat small intestinal epithelial mRNA expression and protein levels during chemotherapeutic damage and regeneration. J Histochem Cytochem 2002; 50: 1525-1536.
16. Beck PL, Wong JF, Li Y et al. Chemotherapy- and radiotherapy-induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology 2004; 126: 796-808.
17. Fegan C, Poynton CH, Whittaker JA. The gut mucosal barrier in bone marrow transplantation. Bone Marrow Transplant 1990; 5: 373-377.